Algenuity develops green solution for pharma with algae platform

[UK] Algenuity, based in the UK, is focused on using algae to develop therapeutic agents, and has received assistance on the project from ERA CoBioTech. The latter is a project financed by the EU’s Horizon 2020 programme, which gives selected projects capital whilst also providing scientific expertise.

 

View full article at: Algenuity develops green solution for pharma with algae platform

Contact Algae World News for algae industry advertising and other opinions: info@algaeworld.org 

 

 

 

 

Leave a Reply